Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Case ReportImages in Rheumatology

Erdheim-Chester Disease

YUNA LEE and DAWN PEARCE
The Journal of Rheumatology September 2010, 37 (9) 1962-1963; DOI: https://doi.org/10.3899/jrheum.100255
YUNA LEE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: leeyuna@smh.toronto.on.ca
DAWN PEARCE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Erdheim-Chester disease (ECD) is a rare disease that includes sclerosis in the upper and lower extremities and extraskeletal involvement. No standard therapy exists, but interferon-α has helped some patients. The prognosis for patients with this condition is poor.

ECD is characterized by a symmetrical sclerosis at the diametaphyseal portions of the upper and lower extremities with additional extraskeletal involvement1 including the kidney and retroperitoneum, lung, pericardium, skin, orbit, and brain. Infiltration of the pituitary stalk may lead to diabetes insipidus2. Skeletal involvement is characteristically bilateral and symmetric, with a characteristic bone scan finding of increased uptake in metaphyses and diaphyses of the long bones, usually sparing epiphyses.

A 56-year-old man with a history of central diabetes insipidus presented with an 8-month history of right-side leg pain. On clinical examination, exophthalmos was noted. The plain radiographs of his extremities (Figure 1) showed coarsened trabecular pattern and sclerosis mainly in the metaphyses. Delayed images in a whole-body bone scan (Figure 2) showed intense increased uptake in a bilateral symmetric distribution involving the metadiaphyseal regions of the tibias and femurs. Diagnosis of ECD was based on the results of plain radiographs and a whole-body bone scan.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Within the distal femur and proximal tibia is a diffuse symmetric diametaphyseal process showing mixed sclerosis (arrows) and slight lucency.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Delayed image in a whole-body bone scan shows intense increased uptake in a bilateral symmetric distribution involving the metadiaphyseal regions of the tibias and femur (arrows). To a lesser extent, similar findings are noted in the forearms.

Our patient was also found to have pulmonary cystic disease, 1-cm soft tissue surrounding both kidneys and the mesenteric vessels, a splenomegaly (Figure 3), and bilateral symmetrical enhancing soft tissue mass within the superior extraconal aspect of both orbits (Figure 4). The diagnosis of ECD was confirmed histologically by a kidney biopsy. It showed dendritic cells rich in a perirenal fibrotic process with lipid-laden histiocytes and Touton-type giant cells, which were positive for CD68 and negative for S-100, consistent with a diagnosis of ECD.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Axial image of a contrast-enhanced computed tomography abdomen scan shows 1-cm soft tissue surrounding both kidneys (white arrows). A soft tissue mass surrounds the mesenteric blood vessels (black arrow).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Sagittal T1-weighted image of the brain shows a soft tissue mass in the superior extraconal aspect of the orbit (arrow). This is seen bilaterally.

The prognosis of patients with ECD is poor. The survival of patients at 3 years is about 59%. The causes of mortality are often from respiratory distress, cardiac failure, or pulmonary fibrosis2.

There is no standard therapy for this disorder, although responses to interferon-α have been reported in some patients. Bisphosphonates and steroid have shown some positive effect for bony pain2. Our patient has now been treated with interferon-α 2b for 1.5 years. On this treatment, his leg pain has mostly disappeared, with improving exophthalmos.

    REFERENCES

    1. 1.↵
      1. Khamseh ME,
      2. Mollanai S,
      3. Hashemi F,
      4. Rezaizadeh A,
      5. Azizi F
      . Erdheim-Chester syndrome, presenting as hypogonadotropic hypogonadism and diabetes insipidus. J Endocrinol Invest 2002;25:727–9.
      OpenUrlPubMed
    2. 2.↵
      1. Braiteh F,
      2. Boxrud C,
      3. Esmaeli B,
      4. Kurzrock R
      . Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha. Blood 2005;106:2992–4.
      OpenUrlAbstract/FREE Full Text
    View Abstract
    PreviousNext
    Back to top

    In this issue

    The Journal of Rheumatology
    Vol. 37, Issue 9
    1 Sep 2010
    • Table of Contents
    • Table of Contents (PDF)
    • Index by Author
    • Editorial Board (PDF)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about The Journal of Rheumatology.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Erdheim-Chester Disease
    (Your Name) has forwarded a page to you from The Journal of Rheumatology
    (Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Erdheim-Chester Disease
    YUNA LEE, DAWN PEARCE
    The Journal of Rheumatology Sep 2010, 37 (9) 1962-1963; DOI: 10.3899/jrheum.100255

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

     Request Permissions

    Share
    Erdheim-Chester Disease
    YUNA LEE, DAWN PEARCE
    The Journal of Rheumatology Sep 2010, 37 (9) 1962-1963; DOI: 10.3899/jrheum.100255
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One
    Bookmark this article

    Jump to section

    • Article
      • REFERENCES
    • Figures & Data
    • Info & Metrics
    • References
    • PDF
    • eLetters

    Related Articles

    Cited By...

    More in this TOC Section

    • Adult-Onset Still Disease After ChAdOx1 nCOV-19 Vaccination
    • Development of Pulmonary Alveolar Proteinosis in a Patient With Adult-Onset Still Disease Treated With Tocilizumab
    • A Rare Case of Subcutaneous Sarcoidosis in Patient With Psoriatic Arthritis
    Show more Images in Rheumatology

    Similar Articles

    Content

    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology

    Resources

    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies

    Subscribers

    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions

    More

    • About Us
    • Contact Us
    • My Alerts
    • My Folders
    • Privacy/GDPR Policy
    • RSS Feeds
    The Journal of Rheumatology
    The content of this site is intended for health care professionals.
    Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
    Print ISSN: 0315-162X; Online ISSN: 1499-2752
    Powered by HighWire